1. Home
  2. VBNK vs MDXG Comparison

VBNK vs MDXG Comparison

Compare VBNK & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VersaBank

VBNK

VersaBank

N/A

Current Price

$19.84

Market Cap

622.7M

Sector

Finance

ML Signal

N/A

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

N/A

Current Price

$4.51

Market Cap

625.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VBNK
MDXG
Founded
1980
2006
Country
Canada
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
622.7M
625.6M
IPO Year
2016
2007

Fundamental Metrics

Financial Performance
Metric
VBNK
MDXG
Price
$19.84
$4.51
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$13.00
$9.00
AVG Volume (30 Days)
79.0K
1.1M
Earning Date
06-03-2026
04-29-2026
Dividend Yield
0.41%
N/A
EPS Growth
N/A
14.29
EPS
N/A
N/A
Revenue
N/A
$418,630,000.00
Revenue This Year
$30.02
N/A
Revenue Next Year
$27.30
$13.02
P/E Ratio
$25.91
N/A
Revenue Growth
N/A
19.99
52 Week Low
$10.85
$3.03
52 Week High
$24.42
$7.97

Technical Indicators

Market Signals
Indicator
VBNK
MDXG
Relative Strength Index (RSI) 51.99 63.54
Support Level $18.90 $4.11
Resistance Level $20.56 $5.31
Average True Range (ATR) 0.49 0.15
MACD 0.09 0.02
Stochastic Oscillator 64.59 71.09

Price Performance

Historical Comparison
VBNK
MDXG

About VBNK VersaBank

VersaBank is a Schedule I Canadian bank that provides mainly commercial lending and banking services to select niche markets in Canada and the United States. Its products and services include credit assets, deposits, and cybersecurity services through its wholly owned subsidiary. The bank operates through four segments: Digital Banking Canada and Digital Banking USA, both using a business-to-business model with proprietary financial technology to serve underserved markets; DRTC, which provides cybersecurity services and banking and financial technology development; and Digital Meteor, which owns proprietary technology supporting next-generation digital assets, including Real Bank Deposit Tokens (RBDTs). The majority of revenue comes from Digital Banking.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: